Investing to meet the scientific challenges of HIV/AIDS

Health Affairs

Volumn 28, Issue 6, 2009, Pages 1629-1641

  Fauci, Anthony S ^a   Folkers, Gregory K ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b NIAID

Author keywords

[No Author keywords available]

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS VACCINE; MICROBICIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; CONFERENCE PAPER; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE PLANNING; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; LATENT VIRUS INFECTION; MEDICAL RESEARCH; MIXED INFECTION; NONHUMAN; PANDEMIC; VIRUS LOAD; VIRUS TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AIDS VACCINES; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTI-RETROVIRAL AGENTS; HEALTH EXPENDITURES; HIV INFECTIONS; HUMANS; PANDEMICS; RESEARCH SUPPORT AS TOPIC; WORLD HEALTH;

EID: 76449083128     PISSN: 02782715     EISSN: 15445208     Source Type: Journal    
DOI: 10.1377/hlthaff.28.6.1629     Document Type: Conference Paper

References (34)

1. A map showing the spread of the pandemic is available online at http://content.healthaffairs.org/cgi/content/full/28/6/1629/DC1.
2. Joint United Nations Programme on HIV/AIDS (UNAIDS). 2008 report on the global epidemic. Geneva (Switzerland): UNAIDS; 2008.
3. World Health Organization. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2009. Geneva (Switzerland): WHO; 2009.
4. Centers for Disease Control and Prevention. HIV/AIDS surveillance report. 2007. Atlanta (GA): CDC; 2009. p. 19.
5. Centers for Disease Control and Prevention. HIV prevalence estimates - United States, 2006. MMWR Morb Mortal Wkly Rep. 2008 Oct 3;57(39):1073-6.
6. Hall HI, Song R, Rhodes P, Prejean J, An Q, Lee LM, et aL Estimation of HIV incidence in the United States. JAMA. 2008;300(5):520-9.
7. Richman DD, Margolis DM, Delaney M, Greene WC, Hazuda D, Pomerantz RJ. The challenge of finding a cure for HIV infection. Science. 2009;323(5919):1304- 7.
8. Chun TW, Fauci AS. Latent reservoirs of HIV: obstacles to the eradication of virus. Proc Natl Acad Sci U S A 1999;96(20):10958-61.
9. Chun TW, Justement JS, Moir S, Hallahan CW, Maenza J, Mullins JI, et aL Decay of the HIV reservoir in patients receiving antiretroviral therapy for extended periods: implications for eradication of virus. J Infect Dis. 2007:195(12):1762-4.
10. Haase AT. Perils at mucosal front lines for HIV and SIV and their hosts. Nat Rev Immunol. 2005;5(10)783-92.
11. Chun TW, Nickle DC, Justement JS, Large D, Semerjian A, Curlin ME, et al. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J Clin Invest. 2005;115(11):3250-5.
12. Hütter G, Nowak D, Mossner M, Ganepola S, Müssig A, Allers K, et aL Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N Engl J Med. 2009;360(7):692-8.
13. Walensky RP, Wolf LL, Wood R, Fofana MO, Freedberg KA, Martinson NA, et at. When to start antiretroviral therapy in resource-limited settings. Ann Intern Med. 2009;151(3):157-66.
14. AIDS Vaccine Advocacy Coalition. Piecing together the HIV prevention puzzle. New York AVAC; 2009.
15. Padian NS, Buvé A, Balkus J, Serwadda D, Cates W Jr. Biomedical interventions to prevent HIV infection: evidence, challenges, and way forward. Lancet. 2008;372(9638):585-99.
16. Attia S, Egger M, Müller M, Zwahlen M, Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy; systematic review and meta-analysis. AIDS. 2009;23(11):1397-404.
17. Wood E, Kerr T, Marshall BD, Li K, Zhang R, Hogg RS, et at. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009; 338:b1649.
18. Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373(9657):48-57.
19. Dieffenbach CW, Fauci AS. Universal voluntary testing and treatment for prevention of HIV transmission. JAMA. 2009;301(22):2380-2.
20. Lederman MM, Offord RE, Hartley O. Microbicides and other topical strategies to prevent vaginal transmission of HIV. Nat Rev Immunol. 2006;6(5):371-82.
21. National Institute of Allergy and Infectious Diseases [Internet]. Bethesda (MD): NIAID; c2009. Press release, Anti-HIV gel shows promise in large-scale study in women; 2009 Feb 9 [cited 2009 Aug 23]; [1 screen]. Available from httpy/www3.niaid.nih.gov/news/newsreleases/2009/HPTN-035-gel.htm
22. Barnabas RV, Wasserheit JN. Riddle of the Sphinx revisited the role of STDs in HIV prevention. Sex Transm Dis. 2009;36(6):365-7.
23. White RG, Orrodi KK, Glynn JR, Freeman EE, Bakker R, Habbema JD, et al. Treating curable sexually transmitted infections to prevent HIV in Africa: still an effective control strategy? J Acquir Immune Defic Syndr. 2008;47(3):346-53.
24. Delany-Moretlwe S, Lingappa JR, Celum C. New insights on interactions between HIV-1 and HSV-2. Curr Infect Dis Rep. 2009;11(2):135-42.
25. White R, Celum C, Wasserheit J, Aral S, Hayes R. Control of sexually transmitted infections for HIV prevention. Lancet. 2008;372(9646):1297.
26. Hotez PJ, Molyneux DH, Stillwaggon E, Bentwich Z, Kumaresan J. Neglected tropical diseases and HIV/AIDS. Lancet. 2006;368(9550):1865-6.
27. Johnston MI, Fauci AS. An HIV vaccine - challenges and prospects. N Engl J Med 2008;359(9):888-90.
28. Fauci AS, Johnston MI, Dieffenbach CW, Burton DR, Hammer SM, Hoxie JA, et al. HIV vaccine research: the way forward Science. 2008;321(5888):530-2.
29. National Institute of Allergy and Infectious Diseases [Internet]. Bethesda (MD): NIAID; c2009. Press release, HIV vaccine regimen demonstrates modest preventive effect in Thailand clinical study, 2009 Sep 24 [cited 2009 Sep 24]; [about 2 screens]. Available from: http://www3.niaid.nih.gov/news/ newsreleases/2009/ThaiVaxStudy.htm
30. Kaiser Family Foundation. Financing the response to AIDS in low- and middle-income countries: international assistance from the G8, European Commission and other donor governments in 2009 [Internet]. Menlo Park (CA): Kaiser Family Foundation; [updated 2009 Jul; cited 2009 Sep 17]. Available from: httpy/www.kff.org/hivaids/upload/7347-052.pdf
31. National Institutes of Health. Estimates of funding for various research, condition, and disease categories (RCDC) [Internet]. Bethesda (MD): NIH; 2009 Jan 15 [cited 2009 Sep 28]. Available from: http://report.nih.gov/rcdc/ categories
32. National Institutes of Health Budget Office. Personal communication. 2009 Sep 24.
33. HIV Vaccines and Microbicides Tracking Group. Adapting to realities: trends in HIV prevention research funding 2000 to 2008 [Internet]; 2009 Jul [cited 2009 Sep 24]. Available from: http://www.hivresourcetracking.org/ downloads/Adapting-to-Realities.July.2009.pdf
34. Beck EJ, Avila C, DeLay PR. International and domestic funding for HIV research: how much and how is it spent? HIV Ther. 2009;3(4):307-10.